• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[丙酸倍氯米松治疗前后哮喘患者呼气峰值流速的昼夜节律]

[Circadian rhythms in peak expiratory flow rate of asthmatic patients before and after treatment with beclomethasone dipropionate].

作者信息

Iwasaki Y, Hashinoto S, Hashikura H, Mizobuchi K, Arimoto T, Ito H, Gotoh T, Hara H, Nakamura T, Nakagawa M

机构信息

Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.

出版信息

Nihon Kyobu Shikkan Gakkai Zasshi. 1995 May;33(5):483-8.

PMID:7609332
Abstract

Asthmatic patients have a circadian rhythm in peak expiratory flow rate (PEFR). The present study was done to measure the effect of inhaled beclomethasone dipropionate (BDP) on the circadian rhythm of PEFR in asthmatic patients. After two weeks of observation, BDP (400 micrograms) was given by metered dose inhaler to nine asthmatic patients. The dose of inhaled BDP (800-1200 micrograms) was increased every two weeks until PEFR varied by no more than 20% each day. PEFR was measured four times daily: on waking, around noon, in the evening, and at bedtime. Nine asthmatic patients had a significant (p < 0.05) rhythm detectable by single cosinor analysis, both during the observation period and during treatment. Analysis by the group mean-cosinor method showed that the mean mesor was 397.3 +/- 6.8 l/min, the mean amplitude was 54.3 +/- 7.1 l/min, and the mean acrophase was at 16:31 +/- 0.27 before treatment. After treatment, the mean mesor was 543.8 +/- 4.4 l/min, the mean amplitude was 30.5 +/- 4.9 l/minm, and the mean acrophase was at 16:25 +/- 0.31. The mean mesor had increased significantly (p < 0.05), and the mean amplitude had decreased significantly (p < 0.05) after treatment. The mean acrophase did not change. These data indicate that inhaled BDP increases PEFR at a constant acrophase in asthmatic patients.

摘要

哮喘患者的呼气峰值流速(PEFR)存在昼夜节律。本研究旨在测量吸入丙酸倍氯米松(BDP)对哮喘患者PEFR昼夜节律的影响。经过两周的观察后,通过定量吸入器给9名哮喘患者使用BDP(400微克)。每两周增加吸入BDP的剂量(800 - 1200微克),直至PEFR每天的变化不超过20%。每天测量PEFR四次:醒来时、中午前后、晚上和就寝时。9名哮喘患者在观察期和治疗期间,通过单余弦分析均检测到显著(p < 0.05)的节律。通过组均值 - 余弦分析方法显示,治疗前平均中值为397.3 +/- 6.8升/分钟,平均振幅为54.3 +/- 7.1升/分钟,平均峰相位在16:31 +/- 0.27。治疗后,平均中值为543.8 +/- 4.4升/分钟,平均振幅为30.5 +/- 4.9升/分钟,平均峰相位在16:25 +/- 0.31。治疗后平均中值显著增加(p < 0.05),平均振幅显著降低(p < 0.05)。平均峰相位未改变。这些数据表明,吸入BDP可使哮喘患者在恒定的峰相位下增加PEFR。

相似文献

1
[Circadian rhythms in peak expiratory flow rate of asthmatic patients before and after treatment with beclomethasone dipropionate].[丙酸倍氯米松治疗前后哮喘患者呼气峰值流速的昼夜节律]
Nihon Kyobu Shikkan Gakkai Zasshi. 1995 May;33(5):483-8.
2
Timing of lowest and highest peak expiratory flow in patients with asthma: influence of anti-inflammatory treatment.
Respir Med. 2000 Apr;94(4):385-90. doi: 10.1053/rmed.1999.0752.
3
Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.丙酸倍氯米松超细微粒吸入器(每日400微克)与布地奈德干粉吸入器(每日800微克)治疗哮喘的对比
Int J Clin Pract. 2001 Mar;55(2):100-6.
4
Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.使用都保装置吸入800微克布地奈德与使用带储雾罐的压力定量气雾剂吸入≥1500微克二丙酸倍氯米松在哮喘管理方面疗效相当。法国布地奈德试验组。
Adv Ther. 1996 Jan-Feb;13(1):38-50.
5
[Optimal time of the day for measuring peak expiratory flow rates in patients with asthma].[哮喘患者测量呼气峰值流速的最佳时间]
Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Aug;34(8):885-9.
6
[Effect of low dose of inhaled corticosteroid combined with small dose of oral theophylline on treatment of bronchial asthma].低剂量吸入性糖皮质激素联合小剂量口服茶碱治疗支气管哮喘的疗效
Zhonghua Jie He He Hu Xi Za Zhi. 2000 Jun;23(6):336-9.
7
[The clinical benefit of high dose inhalation therapy with beclomethasone dipropionate for patients with chronic bronchial asthma].[高剂量丙酸倍氯米松吸入疗法对慢性支气管哮喘患者的临床益处]
Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Jan;29(1):59-64.
8
Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.改用不含氯氟烃的吸入性糖皮质激素:HFA-倍氯米松二丙酸酯和CFC-倍氯米松二丙酸酯定量气雾剂的疗效对比研究。
Int J Clin Pract. 1999 Jul-Aug;53(5):331-8.
9
Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler.通过都保吸入布地奈德:一种比通过准纳器吸入二丙酸倍氯米松更有效的哮喘治疗方法。
Ann Allergy Asthma Immunol. 1995 Aug;75(2):107-11.
10
Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.丙酸倍氯米松与布地奈德吸入混悬液治疗轻度至中度持续性哮喘儿童的疗效比较
Eur Rev Med Pharmacol Sci. 2001 Jan-Feb;5(1):17-24.